Annual report pursuant to Section 13 and 15(d)

Condensed Consolidating Financial Information (Details 1)

v2.4.0.6
Condensed Consolidating Financial Information (Details 1) (USD $)
In Millions, unless otherwise specified
3 Months Ended 12 Months Ended
Feb. 29, 2012
Nov. 30, 2011
Aug. 31, 2011
May 31, 2011
Feb. 28, 2011
Nov. 30, 2010
Aug. 31, 2010
May 31, 2010
Feb. 28, 2010
Feb. 29, 2012
Feb. 28, 2011
Feb. 28, 2010
Condensed Consolidating Statement of Operations                        
Sales                   $ 2,979.1 $ 4,096.7 $ 4,213.0
Less - excise taxes                   (324.8) (764.7) (848.2)
Net sales 628.1 700.7 690.2 635.3 715.3 966.4 862.8 787.5   2,654.3 3,332.0 3,364.8
COST OF PRODUCT SOLD                   (1,592.2) (2,141.9) (2,220.0)
Gross profit 245.2 282.9 283.0 251.0 254.0 351.9 314.2 270.0   1,062.1 1,190.1 1,144.8
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES                   (521.5) (640.9) (682.5)
IMPAIRMENT OF INTANGIBLE ASSETS         (16.7) (6.9)     (103.2) (38.1) (23.6) (103.2)
RESTRUCTURING CHARGES                   (16.0) (23.1) (47.6)
Operating income                   486.5 502.5 311.5
Equity in earnings (losses) of equity method investees and subsidiaries                   228.5 243.8 213.6
INTEREST EXPENSE, net                   (181.0) (195.3) (265.1)
LOSS ON WRITE-OFF OF FINANCING COSTS                       (0.7)
Income (loss) before income taxes                   534.0 551.0 259.3
(PROVISION FOR) BENEFIT FROM INCOME TAXES                   (89.0) 8.5 (160.0)
Net income (loss) 103.0 104.8 162.7 74.5 279.8 139.3 91.3 49.1   445.0 559.5 99.3
Parent Company [Member]
                       
Condensed Consolidating Statement of Operations                        
Sales                   1,319.1 726.0 689.8
Less - excise taxes                   (169.2) (136.9) (147.4)
Net sales                   1,149.9 589.1 542.4
COST OF PRODUCT SOLD                   (864.3) (312.7) (288.5)
Gross profit                   285.6 276.4 253.9
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES                   (233.0) (306.9) (251.4)
RESTRUCTURING CHARGES                   (4.3) (1.3) (0.8)
Operating income                   48.3 (31.8) 1.7
Equity in earnings (losses) of equity method investees and subsidiaries                   590.5 735.9 273.6
INTEREST EXPENSE, net                   (256.5) (213.3) (257.8)
LOSS ON WRITE-OFF OF FINANCING COSTS                       (0.7)
Income (loss) before income taxes                   382.3 490.8 16.8
(PROVISION FOR) BENEFIT FROM INCOME TAXES                   62.7 68.7 82.5
Net income (loss)                   445.0 559.5 99.3
Subsidiary Guarantors [Member]
                       
Condensed Consolidating Statement of Operations                        
Sales                   1,721.4 1,916.1 1,803.9
Less - excise taxes                   (93.5) (96.6) (95.0)
Net sales                   1,627.9 1,819.5 1,708.9
COST OF PRODUCT SOLD                   (1,063.2) (1,173.1) (1,067.6)
Gross profit                   564.7 646.4 641.3
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES                   (180.1) (262.0) (236.8)
IMPAIRMENT OF INTANGIBLE ASSETS                     (6.9)  
RESTRUCTURING CHARGES                   (7.7) (7.1) (14.9)
Operating income                   376.9 370.4 389.6
Equity in earnings (losses) of equity method investees and subsidiaries                   240.3 246.3 265.9
INTEREST EXPENSE, net                   70.4 14.6 (1.7)
Income (loss) before income taxes                   687.6 631.3 653.8
(PROVISION FOR) BENEFIT FROM INCOME TAXES                   (158.5) (251.1) (278.4)
Net income (loss)                   529.1 380.2 375.4
Subsidiary Nonguarantors [Member]
                       
Condensed Consolidating Statement of Operations                        
Sales                   702.6 1,904.7 2,097.1
Less - excise taxes                   (62.1) (531.2) (605.8)
Net sales                   640.5 1,373.5 1,491.3
COST OF PRODUCT SOLD                   (380.2) (1,006.6) (1,150.2)
Gross profit                   260.3 366.9 341.1
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES                   (157.0) (175.3) (282.2)
IMPAIRMENT OF INTANGIBLE ASSETS                   (38.1) (16.7) (103.2)
RESTRUCTURING CHARGES                   (4.0) (14.7) (31.9)
Operating income                   61.2 160.2 (76.2)
Equity in earnings (losses) of equity method investees and subsidiaries                   4.3 8.3 (18.8)
INTEREST EXPENSE, net                   5.1 3.4 (5.6)
Income (loss) before income taxes                   70.6 171.9 (100.6)
(PROVISION FOR) BENEFIT FROM INCOME TAXES                   6.5 194.1 32.9
Net income (loss)                   77.1 366.0 (67.7)
Eliminations [Member]
                       
Condensed Consolidating Statement of Operations                        
Sales                   (764.0) (450.1) (377.8)
Net sales                   (764.0) (450.1) (377.8)
COST OF PRODUCT SOLD                   715.5 350.5 286.3
Gross profit                   (48.5) (99.6) (91.5)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES                   48.6 103.3 87.9
Operating income                   0.1 3.7 (3.6)
Equity in earnings (losses) of equity method investees and subsidiaries                   (606.6) (746.7) (307.1)
Income (loss) before income taxes                   (606.5) (743.0) (310.7)
(PROVISION FOR) BENEFIT FROM INCOME TAXES                   0.3 (3.2) 3.0
Net income (loss)                   $ (606.2) $ (746.2) $ (307.7)